Case of acute anterior uveitis and Vogt–Koyanagi–Harada syndrome-like eruptions induced by nivolumab in a melanoma patient

Journal of Dermatology

Volumn 44, Issue 8, 2017, Pages 975-976

  Arai, Takashi ^a   Harada, Kazutoshi ^a   Usui, Yoshihiko ^a   Irisawa, Ryokichi ^a   Tsuboi, Ryoji ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA INTERFERON; HLA A11 ANTIGEN; HLA A31 ANTIGEN; HLA B51 ANTIGEN; HLA B62 ANTIGEN; HLA DRB1 ANTIGEN; LEUKOCYTE ANTIGEN; MELANIN; NIVOLUMAB; STEROID; THYROTROPIN; UNCLASSIFIED DRUG; HLA ANTIGEN; IMMUNOLOGICAL ANTINEOPLASTIC AGENT;

ACUTE ANTERIOR UVEITIS; ADHESION; ADULT; ALLELE; ALOPECIA AREATA; ANTERIOR EYE CHAMBER; BLURRED VISION; CANCER PATIENT; CASE REPORT; DEPIGMENTATION; DERMAL PAPILLA; DISEASE ASSOCIATION; GENOTYPE; HLA DRB1 GENE; HLA TYPING; HUMAN; HUMAN TISSUE; LETTER; LUNG METASTASIS; LUNG SURGERY; LYMPHOCYTIC INFILTRATION; MALE; MELANOMA; MIDDLE AGED; POLIOSIS; SEROTYPE; SKIN BIOPSY; SLIT LAMP MICROSCOPY; TREATMENT DURATION; UVEITIS; VITILIGO; VOGT KOYANAGI SYNDROME; CHEMICALLY INDUCED; GENETICS; IRIDOCYCLITIS; LUNG TUMOR; MENINGOENCEPHALITIS; PATHOLOGY;

ANTINEOPLASTIC AGENTS, IMMUNOLOGICAL; HLA ANTIGENS; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NIVOLUMAB; UVEITIS, ANTERIOR; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 84988428989     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.13612     Document Type: Letter

References (5)

1. Weber JS, D'Angelo SP, Minor D et al. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol 2015; 16: 375–384.
2. Freeman-Keller M, Kim Y, Cronin H, Richards A, Gibney G, Weber JS. Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes. Clin Cancer Res 2016; 22: 886–894.
3. Sugita S, Takase H, Taguchi C et al. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci 2006; 47: 2547–2554.
4. Papavasileiou E, Prasad S, Freitag SK, Sobrin L, Lobo AM. Ipilimumab-induced ocular and orbital inflammation—a case series and review of the literature. Ocul Immunol Inflamm 2016; 24: 140–146.
5. Shindo Y, Inoko H, Yamamoto T, Ohno S. HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol 1994; 78: 223–226.